Dr. Catherine B. Bowman, MD
Pediatrics (Pediatrics Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatrics Physician primary
GA license 041267
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 7 companies reported 11 payments worth $238 in total to this clinician.
| Corium, LLC | $63.37 |
|---|---|
| Sanofi-aventis U.S. LLC | $48.62 |
| GlaxoSmithKline, LLC. | $42.58 |
| Verrica Pharmaceuticals Inc. | $28.22 |
| Supernus Pharmaceuticals, Inc. | $24.54 |
| Seqirus USA Inc | $16.44 |
| Collegium Pharmaceutical, Inc. | $14.60 |
| Food and Beverage | $238 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $50.00 in research payments for these studies, mostly to the institutions running them.
- Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
AbbVie Inc. · Recruiting · NCT04846959
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.